Swedish Orphan Biovitrum AB (publ)

Common Name

Swedish Orphan Biovitrum

Country

Sweden

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Employees

1,937

Ticker

SOBI

Exchange

NASDAQ STOCKHOLM AB

Website

www.sobi.com

Description

Swedish Orphan Biovitrum AB is an international biopharmaceutical company specializing in the development, manufacturing, and marketing of innovative therapies for rare diseases. Its primary focus lie... Show more

Financial Statements of Swedish Orphan Biovitrum

Below are the financial statements of Swedish Orphan Biovitrum, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Income Statement (as reported) Balance Sheet (as reported)

All figures in millions of SEK	2024	2023
Non-current assets	—	—
Intangible assets	58,971^a	59,580^a
Tangible assets	1,584^a	1,302^a
Financial assets	166^a	142^a
Prepaid production costs	268^a	0^a
Deferred tax assets	1,293^a	844^a
Total non-current assets	62,282^a	61,867^a
Current assets	—	—
Inventories	4,159^a	3,874^a
Accounts receivable	5,195^a	5,169^a
Other receivables	405^a	602^a
Prepaid expenses and accrued income	2,262^a	1,611^a
Cash and cash equivalents	1,140^a	904^a
Total current assets	13,162^a	12,160^a
Total assets	75,444^a	74,027^a
Equity	—	—
Share capital	195^a	194^a
Other contributed capital	17,186^a	16,552^a
Other reserves	981^a	-934^a
Retained earnings	18,039^a	15,646^a
Profit for the year	3,885^a	2,409^a
Equity attributable to parent company shareholders	40,286^a	33,867^a
Non-controlling interests	9^a	0^a
Total equity	40,295^a	33,867^a
Non-current liabilities	—	—
Borrowings	12,407^a	11,356^a
Deferred tax liabilities	6,702^a	6,680^a
Lease liabilities	268^a	168^a
Compensations post-employment benefits	276^a	210^a
Other provisions	52^a	121^a
Other liabilities	2,842^a	2,530^a
Total non-current liabilities	22,549^a	21,065^a
Current liabilities	—	—
Borrowings	3,926^a	8,813^a
Accounts payable	944^a	1,024^a
Tax liabilities	744^a	74^a
Lease liabilities	134^a	148^a
Other provisions	531^a	535^a
Other liabilities	646^a	3,253^a
Accrued expenses and deferred income	5,674^a	5,248^a
Total current liabilities	12,600^a	19,095^a
Total equity and liabilities	75,444^a	74,027^a

Verified Sources Behind Swedish Orphan Biovitrum’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Swedish Orphan Biovitrum’s data sources below and access millions more through our Disclosure Search.

a. Swedish Orphan Biovitrum's Annual Report 2024

Trace every data point back to Swedish Orphan Biovitrum’s disclosures

Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.

Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

At Tracenable, we're exploring the launch of real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?

Explore Peer Companies

Welcome Back to Tracenable

Sign in to your account

Swedish Orphan Biovitrum AB (publ)

Financial Statements of Swedish Orphan Biovitrum

Verified Sources Behind Swedish Orphan Biovitrum’s Financial Fundamentals Data

Access Standardized Financial Statements within Minutes of Disclosure

Explore Peer Companies

Ipsen SA

Teva Pharmaceutical Industries Ltd

Alkem Laboratories Ltd

Glenmark Pharmaceuticals Ltd

Dr Reddy's Laboratories Ltd

Richter Gedeon Vegyeszeti Gyar Nyrt